Rosenblum Silverman Sutton S F Inc Dexcom Inc Transaction History

Rosenblum Silverman Sutton S F Inc

  • $345 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 10, 2018
SELL
$13.06 - $18.54 $377,642 - $536,102
-28,916 Closed
0 $0
Q4 2017

Feb 01, 2018
SELL
$11.12 - $15.38 $450,193 - $622,659
-40,485 Reduced 58.33%
28,916 $1.66 Million
Q3 2017

Oct 27, 2017
BUY
$11.36 - $18.98 $788,395 - $1.32 Million
69,401
69,401 $3.4 Million

Others Institutions Holding DXCM

# of Institutions
1,124
Shares Held
353M
Call Options Held
4.19M
Put Options Held
4.54M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $43.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Rosenblum Silverman Sutton S F Inc Portfolio

Follow Rosenblum Silverman Sutton S F Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenblum Silverman Sutton S F Inc , based on Form 13F filings with the SEC.

News

Stay updated on Rosenblum Silverman Sutton S F Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email